Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $406.2 million versus the consensus estimate of $398.96 million.

• Signed definitive agreement to sell EPSi business unit for $365 million

For earnings history and earnings-related data on Allscripts (MDRX) click here.